Endoscopy · 2024
American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jirapinyo Pichamol, Hadefi Alia, Thompson Christopher C, Patai Árpád V, Pannala Rahul, Goelder Stefan K, Kushnir Vladimir, Barthet Marc, Apovian Caroline M, Boskoski Ivo, Chapman Christopher G, Davidson Paul, Donatelli Gianfranco, Kumbhari Vivek, Hayee Bu, Esker Janelle, Hucl Tomas, Pryor Aurora D, Maselli Roberta, Schulman Allison R, Pattou Francois, Zelber-Sagi Shira, Bain Paul A, Durieux Valérie, Triantafyllou Konstantinos, Thosani Nirav, Huberty Vincent, Sullivan Shelby
Аннотация
This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of ≥30 kg/m2, or with a BMI of 27.0-29.9 kg/m2 with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.